New Jersey Assembly Bill A3957

New Jersey 2022-2023 Regular Session

• Introduced: 5/12/22
• Refer: 5/12/22

Caption

Provides earned time credits to reduce parole eligibility date for inmates who participate in substance abuse treatment program.

Impact

If enacted, A3957 will amend the law governing inmate credit systems, particularly affecting Title 30 of the Revised Statutes of New Jersey. The introduction of this bill is significant for state law as it promotes a more supportive approach to inmate management. By prioritizing rehabilitation through participation in treatment programs, the bill aims to reduce recidivism rates, thereby contributing to public safety and potentially easing prison overcrowding, which has been a growing concern in various states.

Summary

Assembly Bill A3957 aims to provide earned time credits to inmates who actively participate in full-time substance abuse treatment programs. The bill is designed to incentivize rehabilitation by allowing inmates to reduce their parole eligibility date. Under existing laws, certain credit systems, such as commutation or good time credits, are available for inmates not sentenced to a mandatory minimum term. A3957 proposes to enhance these credits by granting 1.5 times the usual amount while the inmate is engaged in treatment, ultimately enabling quicker access to parole for those seeking help with substance abuse issues.

Contention

While the focus on rehabilitation through substance abuse programs is widely viewed as a positive step, there may be points of contention regarding the implementation and effectiveness of such programs within the prison system. Critics might argue about the availability and quality of treatment programs, raising concerns about whether all inmates will genuinely benefit. Additionally, there may be debates on whether this approach adequately addresses the complexities surrounding parole eligibility and if it might inadvertently create disparities in how inmates are treated based on their participation in available programs.